Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Adami

Showing results (51-60 of 141) with videos related to

Pageof 15
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 4, 2017
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis?Maurizio Rossini, Giovanni Adami, Ombretta Viapiana, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2023
Bone Loss in Inflammatory Rheumatic Musculoskeletal Disease Patients Treated With Low-Dose Glucocorticoids and Prevention by Anti-Osteoporosis MedicationsGiovanni Adami, Angelo Fassio, Maurizio Rossini, et al.
Frontiers in Medicine|December 18, 2020
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and TreatmentDenise Rotta, Angelo Fassio, Maurizio Rossini, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 5, 2019
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T CellsAlessandro Giollo, Maurizio Rossini, Davide Gatti, et al.
Annals of the Rheumatic Diseases|July 5, 2019
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendationsGiovanni Orsolini, Irene Elizabeth Maria Bultink, Giovanni Adami, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 26, 2015
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et alMaurizio Rossini, Ombretta Viapiana, Giovanna Zanoni, et al.
International Journal of Molecular Sciences|May 13, 2026
Hajdu-Cheney Syndrome in a Two-Generation Family: Longitudinal Skeletal Progression and Differential Therapeutic Responses in a Mother and Her SonRuggero Lanzafame, Thomas Zoller, Angelo Pietrobelli, et al.
Clinical and Experimental Rheumatology|November 13, 2018
Secukinumab produces a quick increase in WNT signalling antagonists in patients with psoriatic arthritisAngelo Fassio, Davide Gatti, Maurizio Rossini, et al.
Arthritis Research & Therapy|November 7, 2018
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?Giovanni Orsolini, Giovanni Adami, Maurizio Rossini, et al.
Therapeutic Advances in Musculoskeletal Disease|March 28, 2022
Osteoporosis in 10 years time: a glimpse into the future of osteoporosisGiovanni Adami, Angelo Fassio, Davide Gatti, et al.
Pageof 15

Showing results (51-60 of 141) with videos related to

Sort By:
Pageof 15
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 4, 2017
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis?Maurizio Rossini, Giovanni Adami, Ombretta Viapiana, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2023
Bone Loss in Inflammatory Rheumatic Musculoskeletal Disease Patients Treated With Low-Dose Glucocorticoids and Prevention by Anti-Osteoporosis MedicationsGiovanni Adami, Angelo Fassio, Maurizio Rossini, et al.
Frontiers in Medicine|December 18, 2020
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and TreatmentDenise Rotta, Angelo Fassio, Maurizio Rossini, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 5, 2019
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T CellsAlessandro Giollo, Maurizio Rossini, Davide Gatti, et al.
Annals of the Rheumatic Diseases|July 5, 2019
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendationsGiovanni Orsolini, Irene Elizabeth Maria Bultink, Giovanni Adami, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 26, 2015
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et alMaurizio Rossini, Ombretta Viapiana, Giovanna Zanoni, et al.
International Journal of Molecular Sciences|May 13, 2026
Hajdu-Cheney Syndrome in a Two-Generation Family: Longitudinal Skeletal Progression and Differential Therapeutic Responses in a Mother and Her SonRuggero Lanzafame, Thomas Zoller, Angelo Pietrobelli, et al.
Clinical and Experimental Rheumatology|November 13, 2018
Secukinumab produces a quick increase in WNT signalling antagonists in patients with psoriatic arthritisAngelo Fassio, Davide Gatti, Maurizio Rossini, et al.
Arthritis Research & Therapy|November 7, 2018
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?Giovanni Orsolini, Giovanni Adami, Maurizio Rossini, et al.
Therapeutic Advances in Musculoskeletal Disease|March 28, 2022
Osteoporosis in 10 years time: a glimpse into the future of osteoporosisGiovanni Adami, Angelo Fassio, Davide Gatti, et al.
Pageof 15